Prevalence of malignant hyperthermia diagnosis in New York state ambulatory surgery center discharge records 2002 to 2011
Z Lu, H Rosenberg, JE Brady, G Li - Anesthesia & Analgesia, 2016 - journals.lww.com
BACKGROUND: Malignant hyperthermia (MH) is a rare yet potentially fatal
pharmacogenetic disorder triggered by exposure to inhaled anesthetics and the …
pharmacogenetic disorder triggered by exposure to inhaled anesthetics and the …
Prevalence of malignant hyperthermia diagnosis in hospital discharge records in California, Florida, New York, and Wisconsin
Z Lu, H Rosenberg, G Li - Journal of clinical anesthesia, 2017 - Elsevier
Study objective Malignant hyperthermia (MH) is a rare yet potentially fatal pharmacogenetic
disorder triggered by exposure to inhalational anesthetics and the depolarizing …
disorder triggered by exposure to inhalational anesthetics and the depolarizing …
Prevalence of malignant hyperthermia due to anesthesia in New York State, 2001–2005
JE Brady, LS Sun, H Rosenberg, G Li - Anesthesia & Analgesia, 2009 - journals.lww.com
BACKGROUND: Malignant hyperthermia (MH) is a pharmacogenetic syndrome that variably
expresses itself on exposure to triggering agents. MH prevalence in the United States is not …
expresses itself on exposure to triggering agents. MH prevalence in the United States is not …
Trends and outcomes of malignant hyperthermia in the United States, 2000 to 2005
EB Rosero, AO Adesanya, CH Timaran… - The Journal of the …, 2009 - pubs.asahq.org
Background Malignant hyperthermia (MH) is a potentially fatal pharmacogenetic disorder
with an estimated mortality of less than 5%. The purpose of this study was to evaluate the …
with an estimated mortality of less than 5%. The purpose of this study was to evaluate the …
Prevalence of malignant hyperthermia and relationship with anesthetics in Japan: data from the diagnosis procedure combination database
M Sumitani, K Uchida, H Yasunaga… - The Journal of the …, 2011 - pubs.asahq.org
Background Malignant hyperthermia (MH) is a rare but life-threatening disease that occurs
during general anesthesia. The actual prevalence of MH remains unclear, and the …
during general anesthesia. The actual prevalence of MH remains unclear, and the …
Accuracy of malignant hyperthermia diagnoses in hospital discharge records
T Pinyavat, H Rosenberg, BH Lang, CA Wong… - …, 2015 - pubs.asahq.org
Abstract Background: In 1997, the International Classification of Diseases (ICD), 9th
Revision Clinical Modification (ICD-9) coding system introduced the code for malignant …
Revision Clinical Modification (ICD-9) coding system introduced the code for malignant …
Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands
S Riazi, MG Larach, C Hu, D Wijeysundera… - Anesthesia & …, 2014 - journals.lww.com
BACKGROUND: Between 1992 and 2011, 373 Canadian individuals with adverse
anesthetic reaction were referred to the Malignant Hyperthermia Unit in Toronto, Ontario …
anesthetic reaction were referred to the Malignant Hyperthermia Unit in Toronto, Ontario …
Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006
MG Larach, GA Gronert, GC Allen… - Anesthesia & …, 2010 - journals.lww.com
BACKGROUND: We analyzed cases of malignant hyperthermia (MH) reported to the North
American MH Registry for clinical characteristics, treatment, and complications. METHODS …
American MH Registry for clinical characteristics, treatment, and complications. METHODS …
Evaluation of suspected malignant hyperthermia events during anesthesia
F Schuster, S Johannsen, D Schneiderbanger… - BMC …, 2013 - Springer
Background Malignant hyperthermia (MH), a metabolic myopathy triggered by volatile
anesthetics and depolarizing muscle relaxants, is a potentially lethal complication of general …
anesthetics and depolarizing muscle relaxants, is a potentially lethal complication of general …
Malignant hyperthermia in the ambulatory surgery center: how should we prepare?
mia (MH) occurs when a patient who has inherited a causative mutation (usually in RYR1,
the gene on chromosome 19 that encodes for the ryanodine receptor) is exposed to one or …
the gene on chromosome 19 that encodes for the ryanodine receptor) is exposed to one or …